{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:11Z","timestamp":1760955371399,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jocn.2012.02.011","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T08:01:40Z","timestamp":1340784100000},"page":"1201-1209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Multifocal motor neuropathy"],"prefix":"10.1016","volume":"19","author":[{"given":"Suraj Ashok","family":"Muley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.02.011_b0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","article-title":"Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease","volume":"11","author":"Parry","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<243::AID-MUS14>3.0.CO;2-2","article-title":"Multifocal motor neuropathy without overt conduction block","volume":"21","author":"Pakiam","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.58.4.615","article-title":"Axonal multifocal motor neuropathy without conduction block or other features of demyelination","volume":"58","author":"Katz","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp.72.6.761","article-title":"Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block","volume":"72","author":"Nobile-Orazio","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/01.wnl.0000234063.51897.20","article-title":"Multifocal motor neuropathy with and without conduction block: a single entity?","volume":"67","author":"Delmont","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0030","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/01.wnl.0000277697.55288.d0","article-title":"Multifocal motor neuropathy: the diagnostic spectrum and response to treatment","volume":"69","author":"Slee","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S0317167100028894","article-title":"Neuropathy with onion bulb formations and pure motor manifestations","volume":"16","author":"Auer","year":"1989","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.02.011_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410330204","article-title":"Pathological findings at the site of conduction block in multifocal motor neuropathy","volume":"33","author":"Kaji","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mus.880170117","article-title":"Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy","volume":"17","author":"Kaji","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.410390308","article-title":"Sensory nerve pathology in multifocal motor neuropathy","volume":"39","author":"Corse","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0967-5868(98)90198-9","article-title":"Serological evidence for infection with Campylobacter jejuni\/coli in patients with multifocal motor neuropathy","volume":"5","author":"Taylor","year":"1998","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2012.02.011_b0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/WNL.0b013e3181d3e2f6","article-title":"Increased frequency of HLA-DRB1\u221715 in patients with multifocal motor neuropathy","volume":"74","author":"Sutedja","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2003.04651.x","article-title":"Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b","volume":"123","author":"Noguchi","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jocn.2012.02.011_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/keh439","article-title":"Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy","volume":"44","author":"Rodriguez-Escalera","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jocn.2012.02.011_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-005-9060-6","article-title":"Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the nervous system","volume":"78","author":"Stern","year":"2006","journal-title":"J Neurooncol."},{"key":"10.1016\/j.jocn.2012.02.011_b0085","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3899\/jrheum.100072","article-title":"Multifocal motor neuropathy with conduction block following treatment with infliximab","volume":"37","author":"Barber","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocn.2012.02.011_b0090","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1136\/jnnp.2010.226340.185","article-title":"PONM12 multifocal motor neuropathy due to infliximab","volume":"81","author":"Kelly","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF00873973","article-title":"Multifocal motor neuropathy: clinical and electrophysiological findings","volume":"243","author":"Jaspert","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mus.10317","article-title":"Consensus criteria for the diagnosis of multifocal motor neuropathy","volume":"27","author":"Olney","year":"2003","journal-title":"Muscle Nerve"},{"issue":"Pt 1","key":"10.1016\/j.jocn.2012.02.011_b0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/brain\/awg019","article-title":"Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness","volume":"126","author":"Van Asseldonk","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.02.011_b0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mus.21755","article-title":"Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies","volume":"42","author":"O\u2019Ferrall","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.59.1.38","article-title":"Multifocal motor neuropathy with conduction block: a study of 24 patients","volume":"59","author":"Bouche","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mus.880170211","article-title":"Multifocal motor neuropathy: electrodiagnostic features","volume":"17","author":"Chaudhry","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.0b013e3181f0738e","article-title":"Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0135","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y","article-title":"Natural history of 46 patients with multifocal motor neuropathy with conduction block","volume":"23","author":"Taylor","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0140","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mus.21994","article-title":"Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block","volume":"43","author":"Kyriakides","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0145","first-page":"1448","article-title":"Multifocal motor neuropathy\u2013unusual cause of hypoglossal palsy","volume":"99","author":"Axelsson","year":"2002","journal-title":"Lakartidningen"},{"key":"10.1016\/j.jocn.2012.02.011_b0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00415-010-5712-3","article-title":"Cold paresis in multifocal motor neuropathy","volume":"258","author":"Straver","year":"2011","journal-title":"J Neurol"},{"issue":"Suppl.","key":"10.1016\/j.jocn.2012.02.011_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.57.Suppl.35","article-title":"Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy","volume":"57","author":"Comi","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.jocn.2012.02.011_b0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.57.Suppl.46","article-title":"Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy","volume":"57","author":"Leger","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0165","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awf193","article-title":"Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment","volume":"125","author":"Van den Berg-Vos","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.02.011_b0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mus.21855","article-title":"Motor nerve conduction study in cauda equina with high-voltage electrical stimulation in multifocal motor neuropathy and amyotrophic lateral sclerosis","volume":"43","author":"Akaza","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0175","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp.74.9.1329","article-title":"Transcutaneous cervical root stimulation in the diagnosis of multifocal motor neuropathy with conduction block","volume":"74","author":"Arunachalam","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mus.10262","article-title":"Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy","volume":"26","author":"Cappelen-Smith","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/mus.880190702","article-title":"Persistent increased threshold of electrical stimulation selective to motor nerve in multifocal motor neuropathy","volume":"19","author":"Yokota","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0190","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.45.11.2024","article-title":"Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block","volume":"45","author":"Valls-Sole","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.40.1.118","article-title":"A syndrome of asymmetric limb weakness with motor conduction block","volume":"40","author":"Krarup","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0200","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.2005.064816","article-title":"Axon loss is an important determinant of weakness in multifocal motor neuropathy","volume":"77","author":"Van Asseldonk","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0205","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1001\/archneur.63.12.1778","article-title":"Multifocal motor neuropathy with conduction block: slow but not benign","volume":"63","author":"Lange","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0210","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-4598(200010)23:10<1488::AID-MUS4>3.0.CO;2-E","article-title":"Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders","volume":"23","author":"Daube","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0215","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/brain\/123.8.1602","article-title":"Activity-dependent conduction block in multifocal motor neuropathy","volume":"23","author":"Kaji","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.02.011_b0220","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.20434","article-title":"Magnetic stimulation using a triple-stimulation technique in patients with multifocal neuropathy without conduction block","volume":"32","author":"Attarian","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0225","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/01.wnl.0000225048.20239.e4","article-title":"Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test","volume":"67","author":"Nodera","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0230","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mus.20742","article-title":"Triple-stimulation technique in multifocal neuropathy with conduction block","volume":"35","author":"Deroide","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.21843","article-title":"Activity-dependent conduction block in multifocal motor neuropathy","volume":"43","author":"Straver","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","article-title":"Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies","volume":"27","author":"Pestronk","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0245","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.40.11.1747","article-title":"Anti-GM1 IgM antibodies in motor neuron disease and neuropathy","volume":"40","author":"Nobile-Orazio","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ana.410230517","article-title":"Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b","volume":"23","author":"Nardelli","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0255","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.40.5.842","article-title":"Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1\u20133)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy","volume":"40","author":"Shy","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mus.880141002","article-title":"Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies","volume":"14","author":"Pestronk","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0265","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/WNL.38.9.1457","article-title":"Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis","volume":"38","author":"Pestronk","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.410250118","article-title":"Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis","volume":"25","author":"Pestronk","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.410250517","article-title":"Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia","volume":"25","author":"Shy","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.410380118","article-title":"Multifocal motor neuropathy human sera block distal motor nerve conduction in mice","volume":"38","author":"Roberts","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0285","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mus.880160606","article-title":"Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies","volume":"16","author":"Uncini","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0290","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mus.880180404","article-title":"Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer","volume":"18","author":"Harvey","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","article-title":"IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy","volume":"82","author":"Yuki","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mus.880170114","article-title":"Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy","volume":"17","author":"Parry","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0305","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J","article-title":"Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment","volume":"48","author":"Van den Berg-Vos","year":"2000","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"10.1016\/j.jocn.2012.02.011_b0310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study","volume":"124","author":"Leger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.02.011_b0315","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.48.5.1218","article-title":"Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy","volume":"48","author":"Van Es","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0320","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1212\/01.wnl.0000169179.67764.30","article-title":"Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy","volume":"65","author":"Beekman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410300312","article-title":"Immunosuppressive treatment in multifocal motor neuropathy","volume":"30","author":"Feldman","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0330","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal motor neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0335","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0035-3787(07)90358-6","article-title":"Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin","volume":"163","author":"Delmont","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jocn.2012.02.011_b0340","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s004150200013","article-title":"Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment","volume":"249","author":"Van den Berg-Vos","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0345","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.WNL.0000110185.23464.A1","article-title":"How long is IVIg effective in multifocal motor neuropathy?","volume":"62","author":"Terenghi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0350","unstructured":"Cros D, Drake K. Multifocal motor neuropathies with conduction block: Long-term follow-up of ten patients treated with IVIg. Rev Neurol (Paris) 2006;162(Spec No 1):3S46\u201350."},{"key":"10.1016\/j.jocn.2012.02.011_b0355","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0360","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.43.3_Part_1.537","article-title":"High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy","volume":"43","author":"Nobile-Orazio","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp.2007.121756","article-title":"Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients","volume":"79","author":"Leger","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.02.011_b0370","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.410330303","article-title":"Multifocal motor neuropathy: response to human immune globulin","volume":"33","author":"Chaudhry","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0375","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0b013e3181f735ce","article-title":"Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy","volume":"75","author":"Harbo","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0380","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10072-010-0352-z","article-title":"Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report","volume":"31","author":"Dacci","year":"2010","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2012.02.011_b0385","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mus.20524","article-title":"High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy","volume":"34","author":"Brannagan","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.02.011_b0390","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/01.WNL.0000145706.04340.25","article-title":"Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg","volume":"63","author":"Ruegg","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.02.011_b0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nmd.2009.04.013","article-title":"Beneficial effect of rituximab monotherapy in multifocal motor neuropathy","volume":"19","author":"Stieglbauer","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jocn.2012.02.011_b0400","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1529-8027.2010.00270.x","article-title":"An open-label trial of rituximab (Rituxan(R)) in multifocal motor neuropathy","volume":"15","author":"Chaudhry","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jocn.2012.02.011_b0405","first-page":"400","article-title":"Segmental demyelination secondary to axonal degeneration in uremic neuropathy","volume":"46","author":"Dyck","year":"1971","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2012.02.011_b0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.410170306","article-title":"Axonal attenuation and secondary segmental demyelination in myeloma neuropathies","volume":"17","author":"Ohi","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.02.011_b0415","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410220306","article-title":"Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination","volume":"22","author":"Nukada","year":"1987","journal-title":"Ann Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:15:01Z","timestamp":1760822101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586812001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0967586812001348"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.02.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifocal motor neuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2012.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}